Entry note
UBER: Healthcare and biotech catalyst desk
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Uber is back near $378.65, so the desk marked it as actionable. If price loses $361.61, the idea gets downgraded quickly.
$378.65Entry
$361.61Risk rule
$399.48Focus